• Explore /
  • Poster
  • / Phase II trial of bolus 5-FU/l-LV regimen as salvage line chemotherapy for oral fluorouracil resistant unresectable gastric cancer (HGCSG1502).

Phase II trial of bolus 5-FU/l-LV regimen as salvage line chemotherapy for oral fluorouracil resistant unresectable gastric cancer (HGCSG1502).

Abstract Poster

Authors

null

Tetsuhito Muranaka

Division of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan

Tetsuhito Muranaka , Satoshi Yuki , Kentaro Sawada , Yasuyuki Kawamoto , Hiroshi Nakatsumi , Masayoshi Dazai , Michio Nakamura , Atsushi Ishiguro , Susumu Sogabe , Yoshimitsu Kobayashi , Takuto Miyagishima , Ichiro Iwanaga , Miki Tateyama , Kazuteru Hatanaka , Takashi Kato , Naoya Sakamoto , Yuh Sakata , Yoshito Komatsu , Hideyuki Hayashi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000018882

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr TPS177)

DOI

10.1200/jco.2016.34.4_suppl.tps177

Abstract #

TPS177

Poster Bd #

O3

Abstract Disclosures

Similar Posters

First Author: Josep Tabernero

First Author: Ruinuo Jia

First Author: Rui-hua Xu

First Author: Claudia Pauligk